Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways
In the SELECT trial, semaglutide produced sustained weight loss over four years and reduced major cardiovascular events by 20% in people with overweight or obesity and established cardiovascular disease, but without diabetes [2]
These receptors exist throughout the cardiovascular system, and their activation promotes vasodilation and reduces vascular stiffness
Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species
Their ease of use and ability to act systemically make them a convenient option for research and therapeutic purposes
Theyre great for the right person, said Moore, who is also a professor of clinical practice, medicine and internal medicine at the University of Colorado School of Medicine and researches best practices in patient care through the Brown Moore Endowed Chair for Excellence in Patient Experience